The nonapeptide hemopressin, which is derived from the α chain of hemoglobin, has been reported to exhibit inverse agonist activity against the CB1 receptor. Administration of this peptide in animal models led to decreased food intake and elicited hypotensive and antinociceptive effects. On the basis of hemopressin's potential in therapeutic applications and the lack of a structure-activity relationship study in literature, we aimed to determine the conformational features of hemopressin under physiological conditions. We conducted transmission electron microscopy experiments of hemopressin, revealing that it self-assembles into fibrils under aqueous conditions at pH 7.4. Circular dichroism and nuclear magnetic resonance experiments indicate that the peptide adopts a mostly extended β-like structure, which may contribute to its self-assembly and fibril formation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/bm201836f | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Molecular insights into the inhibition of angiotensin-converting enzyme 1 by hemopressin peptides.
Sci Rep
November 2024
Department of Biology College of Science, United Arab Emirates University, PO Box 15551, Al Ain, United Arab, United Arab Emirates.
Article Synopsis
- Inhibiting angiotensin-converting enzyme 1 (ACE1) is crucial for controlling hypertension by blocking the production of angiotensin II, a strong vasoconstrictor.
- There is a growing interest in natural bioactive peptides, particularly hemopressins (Hp), as alternatives to synthetic ACE1 inhibitors due to their potential benefits.
- The study found that the Hp variant with leucine (Hp-L) showed better ACE1 inhibition compared to the variant with phenylalanine (Hp-F), and specific sequences like RVD-Hp-L demonstrated strong binding and inhibitory properties against ACE1.
Injectable pH-responsive polypeptide hydrogels for local delivery of doxorubicin.
Nanoscale Adv
October 2024
Department of Pharmaceutics, School of Pharmacy, State Key Laboratory of Natural Medicines, China Pharmaceutical University Nanjing Jiangsu 211198 China
Cancer, as a global health threat, is often treated with chemotherapy, but its effect is limited, especially the drugs such as doxorubicin (DOX) are limited by their non-specificity and side effects. This study focuses on developing a new drug delivery system to overcome these challenges. Based on the self-assembling peptide hemopressin (HP), we designed and screened FOK peptide, which serves as a pH-responsive carrier with excellent pH sensitivity and mechanical stability.
View Article and Find Full Text PDFHemoglobin α-derived peptides VD-hemopressin (α) and RVD-hemopressin (α) are involved in electroacupuncture inhibition of chronic pain.
Front Pharmacol
October 2024
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Institute of Neuroscience, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Introduction: Knee osteoarthritis (KOA) is a chronic degenerative bone metabolic disease that primarily affects older adults, leading to chronic pain and disability that affect patients' daily activities. Electroacupuncture (EA) is a commonly used method for the treatment of chronic pain in clinical practice. Previous studies indicate that the endocannabinoid system is involved in EA analgesia, but whether endocannabinopeptide VD-hemopressin (α) and RVD-hemopressin (α) derived from hemoglobin chains are involved in EA analgesia is unclear.
View Article and Find Full Text PDFComparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids.
Acta Neuropathol Commun
October 2024
Institute of Biochemistry and Molecular Medicine, University of Bern, Bühlstrasse 28, Bern, 3012, Switzerland.
Article Synopsis
- Multiple sclerosis (MS) is a chronic disease marked by the loss of myelin, leading to neurological problems, and the endocannabinoid system (ECS) is being explored as a potential treatment target.
- A study involving 74 MS patients and 80 controls analyzed lipid levels in cerebrospinal fluid (CSF) and serum, revealing that most lipidomic changes in MS do not match between these two fluids.
- Findings showed that specific lipids, including endocannabinoids, varied by sex and age, emphasizing the need to study eCBs in CSF instead of blood to better understand MS-related changes.
The Endocannabinoid Peptide RVD-Hemopressin Is a TRPV1 Channel Blocker.
Biomolecules
September 2024
Centro de Investigación de Estudios Avanzados del Maule (CIEAM), Vicerrectoría de Investigación y Postgrado, Universidad Católica del Maule, Talca 3460000, Chile.
Neurotransmission is critical for brain function, allowing neurons to communicate through neurotransmitters and neuropeptides. RVD-hemopressin (RVD-Hp), a novel peptide identified in noradrenergic neurons, modulates cannabinoid receptors CB1 and CB2. Unlike hemopressin (Hp), which induces anxiogenic behaviors via transient receptor potential vanilloid 1 (TRPV1) activation, RVD-Hp counteracts these effects, suggesting that it may block TRPV1.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!